Huge congrats to Eden Barragan who presented her dissertation exit seminar today entitled “D-serine is a Determinant of Non-Ionotropic LTD” on a project that she initiated during the COVID19 pandemic with some incredibly cool results we cannot wait to share.
Congrats to Shekib for his first Gray Lab publication! There is substantial evidence that both NMDA receptor (NMDAR) hypofunction and dysfunction of GABAergic neurotransmission contribute to schizophrenia, though the relationship between these pathophysiological processes remains poorly understood. Here, we used
I enjoyed giving a virtual public talk at NeuroFest 2021 entitled: “Reversing Synapse Dysfunction in Neuropsychiatric Disease” Watch it here, my talk begins at 38:15
Congrats to Jon Wong for his first-author publication in the Journal of Neuroscience – and the cover of the final ever print issue! D-serine is the primary NMDA receptor (NMDAR) co-agonist at mature forebrain synapses and is synthesized by the
Biggest congratulations to new Ph.D. recipient Jon Wong who presented his dissertation exit seminar today. Unfortunately it had to be over Zoom due to COVID-19 so we could not all celebrate in person, but Jon did a great job. Hope
D-serine is the primary NMDA receptor (NMDAR) co-agonist at mature forebrain synapses and is synthesized by the enzyme serine racemase (SR) in neurons, though the localization of D-serine release is unknown. Here, we show that SR is postsynaptic and, using
The Gray Lab welcomes Hannah Saeger who rotating in the lab from the Pharmacology/Toxicology graduate group. She graduated from UC Santa Cruz where she worked in a C. elegans laboratory examining the regulation of gene expression during development, specifically the
We all went to a reception at the Willis Tower in Chicago during the 2019 SfN meeting.
In this collaboration with the Swanson lab at UCSF, we show that NMDA-mediated superoxide production requires both a source of calcium influx and agonist binding to the glutamate site of the NMDA receptor (GluN2B subunit to be specific). Thus, both
MK801 is an open-channel blocker of the NMDA receptor pore. That is, when the receptor is activated and the channel opens, MK801 enters the pore and blocks it. Usually, MK801 is used extracellularly, but multiple studies have included it in